by Plus Therapeutics | Feb 18, 2025 | GBM, LM, PBC, Uncategorized
Plus Therapeutics Secures $5.7 Million in Funding to Advance Cancer Research #PSTV News: Plus Therapeutics has successfully closed a private placement with $3.7 million in upfront proceeds and received a $2.0 million advance payment from the Cancer Prevention and...
by Plus Therapeutics | Feb 11, 2025 | GBM, LM, PBC, Uncategorized
Celebrating Strength and Resilience: Patient Appreciation Month At Plus Therapeutics, we are honored to celebrate #PatientAppreciationMonth and recognize the incredible strength, resilience, and courage of patients facing cancer. 🧡 Every day, we are inspired by those...
by Plus Therapeutics | Feb 4, 2025 | GBM
New Clinical Trial Site Now Enrolling – OSUCCC-James Joins ReSPECT-GBM! We are excited to announce that The Ohio State University Comprehensive Cancer Center – James (OSUCCC – James) has joined our ReSPECT-GBM Clinical Trial as a new investigation site, with Principal...
by Plus Therapeutics | Feb 4, 2025 | GBM, LM, PBC, Uncategorized
Honoring Progress and Hope on World Cancer Day 🔬 Today is #WorldCancerDay, a day dedicated to raising awareness, advancing research, and supporting those affected by cancer. At Plus Therapeutics, we recognize the unwavering dedication of patients, caregivers, and...
by Plus Therapeutics | Feb 2, 2025 | Uncategorized
Catch Up on Our Latest Videos – Now on YouTube! Did you miss any of our recent videos? Don’t worry—they’re all available on our Plus Therapeutics YouTube channel! 🔹 Stay informed with expert discussions on cutting-edge cancer research. 🔹 Hear from patients...
Recent Comments